ArticleOncology letters2013

Inhibition of tumor growth and histopathological changes following treatment with a chemokine receptor CXCR4 antagonist in a prostate cancer xenograft model.

Kang Su Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.